Australian owned & operated
Card Payments AvailableVisaMastercardApple Pay
Home/Shop/BPC-157 + TB-500 Blend 20mg
BPC-157 + TB-500 Blend 20mg lyophilised peptide vial – 10mg BPC-157 and 10mg TB-500 per vial, Solatide Biosciences

Images are for illustration purpose only

BPC-157 + TB-500 Blend 20mg

3 Reviews

This listing is for 1 × BPC-157 + TB-500 Blend 20mg vial only. This blend combines BPC-157 (pentadecapeptide, 10mg) and TB-500 (Thymosin Beta-4 analogue, 10mg) in a single lyophilised formulation. Supplied as a lyophilised analytical reference material for in-vitro biochemical assays, peptide interaction studies, and multi-pathway signalling research. Specifications include ≥99% purity and storage at -20°C (long-term).

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | What Is BPC-157? | What Is TB-500? | BPC-157 vs TB-500 | COA & Lab Testing

Current Batch
SOL-WLV-010Now Shipping

This batch has third party test results

3 Tests Available
Test Summary
Purity

Purity

99.20%

HPLC

Pass

Identity

Identity

Confirmed

LC-MS

Pass

Net Peptide Content

Net Peptide Content

BPC-157 – 9.13 mg/ Thymosin Beta-4 – 8.61 mg

Pass

Verified by Freedom Diagnostics|ISO/IEC 17025 Accredited

Official COA Verification

Independent Lab Verification

Scan the QR code to verify this certificate directly on the Freedom Diagnostics secure portal.

Access Code
Sola2605210114
$129.95 AUD
Quantity
1

Product Overview

Understanding BPC-157 + TB-500 Blend 20mg

BPC-157 + TB-500 Blend combines two complementary research peptides in a single 20mg lyophilised formulation for in-vitro laboratory research. BPC-157 (pentadecapeptide, 10mg) focuses on angiogenesis and growth factor signalling, while TB-500 (Thymosin Beta-4 analogue, 10mg) targets actin-binding and cellular motility. This combination enables investigation of synergistic angiogenesis mechanisms and multi-pathway cellular migration in laboratory models. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Synergistic Pathway Studies: Investigate combined angiogenesis and cellular migration mechanisms in experimental models.
•Comparative Peptide Research: Compare combination effects versus individual BPC-157 or TB-500 in multi-pathway investigation.
•Multi-Target Pathway Investigation: Study interactions between growth factor signalling and cytoskeletal regulation systems in vitro.
•Analytical Concentration Studies: In-vitro assays typically utilise 1 nM to 10 μM to establish combined pathway metrics.
This analytical standard is strictly for in-vitro laboratory research use only.

Technical Specifications

Technical Parameter
Laboratory Specification
Purity
≥99% based on available third-party documentation
Composition
BPC-157 (10mg) + TB-500 (10mg)
Total Mass
20mg per vial
BPC-157 MW
1419.53 g/mol
TB-500 MW
4963.44 g/mol
Appearance
White Lyophilised Powder

Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.

Reviews

Customer Reviews

5.0
Based on 3 verified reviews
M
Matthew Hasselby
13/08/2026

The real stuff. Get 40 days from 20mg vial. Pretty good

A
Alex J
18/05/2026

Prompt reply

Prompt reply when I asked a question before paying.

P
Prefer not to say
20/04/2026

Very happy

Very happy :)

Cart

0

Your cart is currently empty.